Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,564,984
+$3,802,949 QoQ
Shares Held
1,170,787
-6.6% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 252 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Sep 30, 2024CallValue
$1,019,700
CallShares
30,000
PutValue
$727,386
PutShares
21,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. CLDX ranks #23 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CLDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,564,984 | 1,170,787 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,762,035 | 1,253,532 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,937,067 | 1,212,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,228,294 | 975,195 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,711,569 | 477,227 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,258,765 | 399,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,365,322 | 93,602 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,019,700 | 30,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $3,674,420 | 108,103 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $727,386 | 21,400 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $1,619,187 | 43,750 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,740,294 | 208,251 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $436,141 | 10,997 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,352,480 | 158,157 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $703,708 | 20,740 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $1,531,024 | 34,351 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $891,400 | 20,000 | Call | Sole | 2023-02-14 | |
| 2022-06-30 | $3,132,752 | 116,200 | Put | Sole | 2022-08-15 | |
| 2022-06-30 | $3,864,527 | 143,343 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,668,296 | 107,701 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,532,887 | 39,671 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $10,406,357 | 505,163 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,607,753 | 205,922 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $405,600 | 31,200 | Call | Sole | 2020-08-14 | |
| 2020-06-30 | $5,597,332 | 430,564 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||